Zinger Key Points
- Oracle partners with Cleveland Clinic, G42 to launch AI-powered global healthcare platform.
- Platform aims to cut costs, boost diagnostics, and support real-time clinical decision-making.
- Discover the top trade setups and strategies beating the S&P this year —live this Wednesday at 6 PM ET. Reserve your free spot now.
Oracle Corp. ORCL on Friday said it is teaming up with Cleveland Clinic and G42 to introduce an artificial intelligence-powered health platform, aiming to redefine healthcare outcomes and delivery systems. This alliance merges clinical, cloud, and AI expertise to accelerate the transition toward data-driven care models.
The initiative will focus on building an AI-first digital infrastructure to improve global public health systems, starting in the United States and the United Arab Emirates, by harnessing Oracle’s suite of tools and both partners’ clinical and AI strengths.
Also Read: Oracle Partners With seQure To Bolster Cybersecurity For Governments, Enterprises
The platform will integrate Oracle Cloud Infrastructure, Oracle’s AI Data Platform, and Oracle Health technologies with Cleveland Clinic’s clinical leadership and G42’s national-scale AI capabilities.
The company said its goal is to build secure, adaptable, and cost-effective care frameworks that broaden access to advanced treatment, improve diagnostic accuracy, reduce healthcare spending, and offer real-time visibility into public health patterns.
The platform is equipped to process vast volumes of real-world health data and give clinicians decision-making support at the point of care. Through the initiative, the line between research and treatment will blur.
“Aging populations, rising costs, and the complexity of care demand a complete reinvention of how healthcare is provided,” said Oracle’s Executive Chairman and CTO Larry Ellison.
Tom Mihaljevic, Cleveland Clinic CEO, called the venture “a bold leap forward” in global care, while Peng Xiao, Group CEO at G42, emphasized the opportunity to build a “health intelligence fabric.”
While still governed by a non-binding agreement, the initiative underscores growing momentum in public-private cooperation to reshape healthcare delivery globally.
Price Action: ORCL shares are trading lower by 0.15% to $159.17 at last check on Friday.
Read Next:
Image via Shutterstock
Edge Rankings
Price Trend
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.